// App-Quantinova.ai

EP529 : REAL WORLD CLINICAL EFFECTIVENESS AND SAFETY OF CT-P10 IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST AUTHORIZATION SAFETY STUDY

Researchers

Presenter

  • Mark Bishton

Principal Investigators

  • Kamel Laribi

  • Gilles Salles

  • Jatinder Harchowal

  • Alberto Bosi

  • Wolfgang Knauf

  • Monica Bocchia

  • SooKyoung Kim

  • Young Nam Lee

  • Pier Luigi Zinzani

Medical Centers

  • Hematology Unit,Azienda Ospedaliero-Universitaria Senese, University of Siena,Siena,Italy

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • City Hospital Campus, Nottingham, United Kingdom

  • Centrum Für Hämatologie und Onkologie Bethanien,Frankfurt,Germany

  • Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

  • Celltrion Healthcare,Incheon,Korea, Republic Of

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • The Royal Marsden Hospital, London, United Kingdom

  • Centre Hospitalier du Mans, Le Mans, France

Locations

  • Italy

  • United Kingdom

  • Germany

  • Republic of South Korea

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • CT-P10

Outcome

  • N/A

Study Design

  • Non Interventional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved